2021
Direct antiviral agents for chronic hepatitis C virus infection improve health-related quality of life significantly in the long term
Atamla M, Khoury J, Dabbah I, Kramsky R, Yaacob A, Veitsman E, Saadi T. Direct antiviral agents for chronic hepatitis C virus infection improve health-related quality of life significantly in the long term. Clinical And Experimental Hepatology 2021, 7: 258-263. PMID: 34712826, PMCID: PMC8527337, DOI: 10.5114/ceh.2021.109192.Peer-Reviewed Original ResearchDirect antiviral agentsChronic hepatitis C virus (HCV) infectionHepatitis C virus infectionQuality of lifeC virus infectionHealth-related qualitySuccessful treatmentVirus infectionAntiviral agentsChronic HCV infectionDAA treatmentExtrahepatic manifestationsHCV infectionLiver diseaseLong termLiver fibrosisObservational studyProfound negative impactNew drugsInfectionHRQLTreatmentAverage timePatientsDrugs
2018
Unexpected bleeding after Exenatide treatment: a causative relationship or a coincidence?
Khoury J, Andrawus E, Bishop B, Azzam Z. Unexpected bleeding after Exenatide treatment: a causative relationship or a coincidence? Endocrine Regulations 2018, 52: 159-162. PMID: 31517602, DOI: 10.2478/enr-2018-0020.Peer-Reviewed Original ResearchConceptsSpontaneous bleedingDiabetes mellitusType II diabetes mellitusYear old patientExenatide treatmentAntidiabetic medicationsExact pathophysiologyOlder patientsCoagulation profileSafety profilePatient historyAbnormal plateletsBleedingSide effectsMuscular bleedingExenatideCausative relationshipEndemic diseaseMellitusPatientsTreatmentFirst reportCurrent eraMedicationsPathophysiology